dMY Technology Group Inc IV - Ordinary Shares - Class A Aktie News

For the better part of the last three years, seemingly nothing has sparked investor interest quite like the evolution of artificial intelligence (AI). Empowering software and systems with the tools to make split-second decisions without human intervention, as well as to become more proficient at their tasks over time, is viewed as a game-changing technology for most industries around the globe.

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world's leading quantum company, today announced the successful completion of its acquisition of Vector Atomic, the leading quantum sensing company based in California. The all-stock transaction significantly expands and rounds out IonQ's quantum technology platform by adding the world's most advanced precision atomic clocks, inertial s...

For most investors, earnings season is the pinnacle of every quarter. Over a six-week period, the stock market's most-influential businesses lift their proverbial hoods and give investors a look at how they've performed over the prior three-month period.

IonQ and Rigetti stock prices have jumped in the past few years, transforming them into multi-billion-dollar companies. RGTI stock has jumped by 5,255% in the last 12 months, bringing its market capitalization to over $12 billion.

The quantum computing rally of 2025 defies conventional logic. IonQ (IONQ 5.14%) up 75%, D-Wave Quantum (QBTS 12.22%) up 289%, Rigetti Computing (RGTI 13.12%) up 162% -- all since January.

There have been several successful investments in the AI realm that have made investors millionaires over the long run. Take the king of AI computing, Nvidia.

Quantum computing holds a lot of promise to impact fields such as climate science, pharmaceuticals, artificial intelligence (AI) modeling, and much more. Many investors are keen on getting in on the ground floor of new tech trends because, as artificial intelligence stocks have proven, buying early can pay off in spades.

Quantum computing's potential lays in revolutionizing drug discovery and finance, yet decoherence and scaling delay its commercialization.